Volumetric YC 申请
Volumetric 在 Winter 2020 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。
- YC 批次
- Winter 2020
- 行业
- HealthcareIndustrial Bio
- 团队规模
- 5
- 状态
- Acquired
- 已发布
- 2020
创始人
Jordan MillerCo-Founder and President
Bagrat GrigoryanCo-Founder, COO
Volumetric 做什么
About Us Volumetric is a recognized world leader in building living multicellular tissues, with a focus on replicating discrete functions of the human body for basic mechanistic biology, laboratory testing and screening, and drug development. Founded in 2018 by Bagrat Grigoryan and Jordan Miller as a spin-out from Rice University, the full potential of our work is to build whole human organ replacements for patients, made from their own cells. Our Technology and Approach We have invented a suite of breakthrough 3D bioprinting technologies, featured on the cover of Science, that can build human tissue with complex blood vessel networks. We are leveraging this technology in the short term to build patient-specific tissues for drug safety and efficacy testing. Patient cells are taken from a biopsy, added to our proprietary 3D printed tissues, and then drug compounds are injected through the blood vessel network to mimic actual drug delivery in humans. Our vision is that our technology will provide rigorous, reproducible, and predictive outcomes for patients, resulting in drastically improved outcomes for diseases like cancer. More broadly, we see the full potential of our mission as being able to produce functional tissue and organ replacements for diseased or damaged vital organs in the body such as the lung, liver, pancreas, kidney, and heart.
Volumetric 的 YC 申请，重建版
Y Combinator 申请
Volumetric，Winter 2020 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Volumetric
Build living multicellular human tissues
We build living human tissues with complex blood vessel networks using proprietary 3D bioprinting technology. Our product replicates discrete human organ functions for biology research, drug testing, and drug safety screening. We take patient cells from biopsies, add them to printed tissues, and deliver drugs through built-in vessels to mimic real human responses. Long term, we aim to replace diseased organs with functional, patient-specific tissues.
We are based in Houston, TX, and the company would remain there after YC.
Houston puts us close to Rice University where our technology started and provides access to biomedical and industrial bio partners. We're rooted here and it's where our team and ecosystem are strongest.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。
常见问题解答
这是 Volumetric 的真实 YC 申请吗？
不是。Y Combinator 对提交的申请保密。这是重建版：使用 Volumetric 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Volumetric 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。
Volumetric 是哪个 YC 批次的？
Volumetric 是 Y Combinator Winter 2020 批次的成员。
谁创立了 Volumetric？
Volumetric 由 Jordan Miller, Bagrat Grigoryan 创立。
Volumetric 做什么？
Volumetric builds living multicellular tissues with a focus on the…
如何阅读完整的重建申请？
创建免费的 Round Funded 账户。YC Insights 中包含 Volumetric 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。
更多 YC 初创公司，例如 Volumetric
